Table 2.
Drug | Malignancy |
---|---|
Thiopurines | Lymphomas Myeloproliferative syndromes Non-melanoma skin cancers Urinary tract cancers Cervical carcinoma |
Anti-TNF | Lymphoma Melanoma |
Anti-TNF + thiopurines | Lymphoma |
Vedolizumab | None identified |
Ustekinumab | None identified |
JAK inhibitors | Unknown |
Methotrexate | Non-melanoma skin cancers |